Fig 1: FBP1 status in patients with breast cancer. (A) Kaplan-Meier curves of disease-free survival in patients with luminal breast cancer. (B) Kaplan-Meier curves of disease-free survival in patients with basal-like breast cancer cell. P-values were calculated according to the log-rank test. FBP1, liver fructose-1,6-bisphosphatase.
Fig 2: Immunohistochemical analysis of HIF-1a, CK5/6 and FBP1 expression levels in human breast cancer. (A) HIF-1a expression was observed in invasive breast cancer (original magnification, ×100). (B) High expression of HIF-1a was detected in tumor cell nuclei (original magnification, ×400). CK5/6 expression was observed within basal-like breast cancer tissue at (C) original magnification, ×200 and (D) original magnification, ×400. (E) The expression of FBP1 in luminal breast cancer tissue (original magnification, ×400). (F) Low nuclear expression of FBP1 was detected in basal-like breast cancer tissue (original magnification, ×400). HIF-1a, hypoxia-inducible factor-1a; FBP1, liver fructose-1,6-bisphophatase; CK5/6, cytokeratin 5/6.
Supplier Page from Abcam for Anti-FBP1 antibody